Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2106796758', 'doi': 'https://doi.org/10.1158/1535-7163.mct-13-0667', 'title': 'Novel ATP-Competitive MEK Inhibitor E6201 Is Effective against Vemurafenib-Resistant Melanoma Harboring the MEK1-C121S Mutation in a Preclinical Model', 'display_name': 'Novel ATP-Competitive MEK Inhibitor E6201 Is Effective against Vemurafenib-Resistant Melanoma Harboring the MEK1-C121S Mutation in a Preclinical Model', 'publication_year': 2014, 'publication_date': '2014-01-22', 'ids': {'openalex': 'https://openalex.org/W2106796758', 'doi': 'https://doi.org/10.1158/1535-7163.mct-13-0667', 'mag': '2106796758', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/24448821'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.mct-13-0667', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'green', 'oa_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Novel_ATP-Competitive_MEK_Inhibitor_E6201_Is_Effective_against_Vemurafenib-Resistant_Melanoma_Harboring_the_MEK1-C121S_Mutation_in_a_Preclinical_Model/22500810/1/files/39960087.pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5015939846', 'display_name': 'Yusuke Narita', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I55881946', 'display_name': 'Eisai (Japan)', 'ror': 'https://ror.org/04vvh7p27', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I55881946']}, {'id': 'https://openalex.org/I146399215', 'display_name': 'University of Tsukuba', 'ror': 'https://ror.org/02956yf07', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I146399215']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yusuke Narita', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan", 'institution_ids': ['https://openalex.org/I55881946', 'https://openalex.org/I146399215', 'https://openalex.org/I55881946', 'https://openalex.org/I146399215']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101578200', 'display_name': 'Kiyoshi Okamoto', 'orcid': 'https://orcid.org/0000-0001-8989-4060'}, 'institutions': [{'id': 'https://openalex.org/I146399215', 'display_name': 'University of Tsukuba', 'ror': 'https://ror.org/02956yf07', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I146399215']}, {'id': 'https://openalex.org/I55881946', 'display_name': 'Eisai (Japan)', 'ror': 'https://ror.org/04vvh7p27', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I55881946']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kiyoshi Okamoto', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan", 'institution_ids': ['https://openalex.org/I146399215', 'https://openalex.org/I55881946']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061459968', 'display_name': 'Megumi Ikemori Kawada', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I146399215', 'display_name': 'University of Tsukuba', 'ror': 'https://ror.org/02956yf07', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I146399215']}, {'id': 'https://openalex.org/I55881946', 'display_name': 'Eisai (Japan)', 'ror': 'https://ror.org/04vvh7p27', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I55881946']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Megumi Ikemori Kawada', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan", 'institution_ids': ['https://openalex.org/I146399215', 'https://openalex.org/I55881946']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035914770', 'display_name': 'Kazuma Takase', 'orcid': 'https://orcid.org/0000-0002-2609-3044'}, 'institutions': [{'id': 'https://openalex.org/I146399215', 'display_name': 'University of Tsukuba', 'ror': 'https://ror.org/02956yf07', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I146399215']}, {'id': 'https://openalex.org/I55881946', 'display_name': 'Eisai (Japan)', 'ror': 'https://ror.org/04vvh7p27', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I55881946']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kazuma Takase', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan", 'institution_ids': ['https://openalex.org/I146399215', 'https://openalex.org/I55881946']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5019354683', 'display_name': 'Yukinori Minoshima', 'orcid': 'https://orcid.org/0000-0002-6351-6624'}, 'institutions': [{'id': 'https://openalex.org/I146399215', 'display_name': 'University of Tsukuba', 'ror': 'https://ror.org/02956yf07', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I146399215']}, {'id': 'https://openalex.org/I55881946', 'display_name': 'Eisai (Japan)', 'ror': 'https://ror.org/04vvh7p27', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I55881946']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Yukinori Minoshima', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan", 'institution_ids': ['https://openalex.org/I146399215', 'https://openalex.org/I55881946']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006210040', 'display_name': 'Kotaro Kodama', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I55881946', 'display_name': 'Eisai (Japan)', 'ror': 'https://ror.org/04vvh7p27', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I55881946']}, {'id': 'https://openalex.org/I146399215', 'display_name': 'University of Tsukuba', 'ror': 'https://ror.org/02956yf07', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I146399215']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kotaro Kodama', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan", 'institution_ids': ['https://openalex.org/I55881946', 'https://openalex.org/I146399215']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074703972', 'display_name': 'Masao Iwata', 'orcid': 'https://orcid.org/0009-0001-4217-6077'}, 'institutions': [{'id': 'https://openalex.org/I146399215', 'display_name': 'University of Tsukuba', 'ror': 'https://ror.org/02956yf07', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I146399215']}, {'id': 'https://openalex.org/I55881946', 'display_name': 'Eisai (Japan)', 'ror': 'https://ror.org/04vvh7p27', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I55881946']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masao Iwata', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan", 'institution_ids': ['https://openalex.org/I146399215', 'https://openalex.org/I55881946']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102859713', 'display_name': 'Norimasa Miyamoto', 'orcid': 'https://orcid.org/0000-0003-0391-1339'}, 'institutions': [{'id': 'https://openalex.org/I146399215', 'display_name': 'University of Tsukuba', 'ror': 'https://ror.org/02956yf07', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I146399215']}, {'id': 'https://openalex.org/I55881946', 'display_name': 'Eisai (Japan)', 'ror': 'https://ror.org/04vvh7p27', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I55881946']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Norimasa Miyamoto', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan", 'institution_ids': ['https://openalex.org/I146399215', 'https://openalex.org/I55881946', 'https://openalex.org/I146399215', 'https://openalex.org/I55881946']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5016642736', 'display_name': 'Kohei Sawada', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I146399215', 'display_name': 'University of Tsukuba', 'ror': 'https://ror.org/02956yf07', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I146399215']}, {'id': 'https://openalex.org/I55881946', 'display_name': 'Eisai (Japan)', 'ror': 'https://ror.org/04vvh7p27', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I55881946']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kohei Sawada', 'raw_affiliation_strings': ["Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan"], 'affiliations': [{'raw_affiliation_string': "Authors' Affiliations:\u20081Eisai Co., Ltd.; and 2Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan", 'institution_ids': ['https://openalex.org/I146399215', 'https://openalex.org/I55881946', 'https://openalex.org/I55881946', 'https://openalex.org/I146399215']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.509, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 28, 'citation_normalized_percentile': {'value': 0.881649, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 93, 'max': 94}, 'biblio': {'volume': '13', 'issue': '4', 'first_page': '823', 'last_page': '832'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11533', 'display_name': 'Mammalian MAP Kinase Signaling Pathways', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11533', 'display_name': 'Mammalian MAP Kinase Signaling Pathways', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13265', 'display_name': 'Chemistry and Applications of Tetrazoles', 'score': 0.9903, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T13779', 'display_name': 'Role of Pim Oncogenes in Tumorigenesis', 'score': 0.9878, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/v600e', 'display_name': 'V600E', 'score': 0.67073905}, {'id': 'https://openalex.org/keywords/selumetinib', 'display_name': 'Selumetinib', 'score': 0.5958587}, {'id': 'https://openalex.org/keywords/mek-inhibition', 'display_name': 'MEK Inhibition', 'score': 0.574544}], 'concepts': [{'id': 'https://openalex.org/C2776131300', 'wikidata': 'https://www.wikidata.org/wiki/Q423111', 'display_name': 'Vemurafenib', 'level': 4, 'score': 0.9704303}, {'id': 'https://openalex.org/C2777658100', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Melanoma', 'level': 2, 'score': 0.7205542}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.68905574}, {'id': 'https://openalex.org/C2776470698', 'wikidata': 'https://www.wikidata.org/wiki/Q21851559', 'display_name': 'V600E', 'level': 4, 'score': 0.67073905}, {'id': 'https://openalex.org/C501734568', 'wikidata': 'https://www.wikidata.org/wiki/Q42918', 'display_name': 'Mutation', 'level': 3, 'score': 0.60029155}, {'id': 'https://openalex.org/C2776087337', 'wikidata': 'https://www.wikidata.org/wiki/Q7448840', 'display_name': 'Selumetinib', 'level': 5, 'score': 0.5958587}, {'id': 'https://openalex.org/C2781249067', 'wikidata': 'https://www.wikidata.org/wiki/Q17142288', 'display_name': 'MEK inhibitor', 'level': 4, 'score': 0.5713383}, {'id': 'https://openalex.org/C166342909', 'wikidata': 'https://www.wikidata.org/wiki/Q845326', 'display_name': 'Allosteric regulation', 'level': 3, 'score': 0.5681217}, {'id': 'https://openalex.org/C176944494', 'wikidata': 'https://www.wikidata.org/wiki/Q1415380', 'display_name': 'Point mutation', 'level': 4, 'score': 0.49911952}, {'id': 'https://openalex.org/C143065580', 'wikidata': 'https://www.wikidata.org/wiki/Q3285695', 'display_name': 'Mutant', 'level': 3, 'score': 0.4952444}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.43730903}, {'id': 'https://openalex.org/C2781018059', 'wikidata': 'https://www.wikidata.org/wiki/Q207609', 'display_name': 'Oncogene', 'level': 4, 'score': 0.43179548}, {'id': 'https://openalex.org/C184235292', 'wikidata': 'https://www.wikidata.org/wiki/Q421851', 'display_name': 'Kinase', 'level': 2, 'score': 0.41794318}, {'id': 'https://openalex.org/C57074206', 'wikidata': 'https://www.wikidata.org/wiki/Q14197552', 'display_name': 'MAPK/ERK pathway', 'level': 3, 'score': 0.3987633}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.35589075}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.28584325}, {'id': 'https://openalex.org/C29537977', 'wikidata': 'https://www.wikidata.org/wiki/Q188941', 'display_name': 'Cell cycle', 'level': 3, 'score': 0.15277669}, {'id': 'https://openalex.org/C2994587330', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Metastatic melanoma', 'level': 3, 'score': 0.14628342}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.11668691}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.093575716}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.080952555}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D007211', 'descriptor_name': 'Indoles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D007783', 'descriptor_name': 'Lactones', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D048369', 'descriptor_name': 'MAP Kinase Kinase 1', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': True}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D001562', 'descriptor_name': 'Benzimidazoles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D001562', 'descriptor_name': 'Benzimidazoles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D001562', 'descriptor_name': 'Benzimidazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007211', 'descriptor_name': 'Indoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007211', 'descriptor_name': 'Indoles', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D007783', 'descriptor_name': 'Lactones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007783', 'descriptor_name': 'Lactones', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D048369', 'descriptor_name': 'MAP Kinase Kinase 1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D048369', 'descriptor_name': 'MAP Kinase Kinase 1', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D020935', 'descriptor_name': 'MAP Kinase Signaling System', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D020935', 'descriptor_name': 'MAP Kinase Signaling System', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016297', 'descriptor_name': 'Mutagenesis, Site-Directed', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D048493', 'descriptor_name': 'Proto-Oncogene Proteins B-raf', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D048493', 'descriptor_name': 'Proto-Oncogene Proteins B-raf', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D048493', 'descriptor_name': 'Proto-Oncogene Proteins B-raf', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077484', 'descriptor_name': 'Vemurafenib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 8, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.mct-13-0667', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.22500810', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Novel_ATP-Competitive_MEK_Inhibitor_E6201_Is_Effective_against_Vemurafenib-Resistant_Melanoma_Harboring_the_MEK1-C121S_Mutation_in_a_Preclinical_Model/22500810/1/files/39960087.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.22500804', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_Novel_ATP-Competitive_MEK_Inhibitor_E6201_Is_Effective_against_Vemurafenib-Resistant_Melanoma_Harboring_the_MEK1-C121S_Mutation_in_a_Preclinical_Model/22500804/1/files/39960081.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.22500798', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legend_from_Novel_ATP-Competitive_MEK_Inhibitor_E6201_Is_Effective_against_Vemurafenib-Resistant_Melanoma_Harboring_the_MEK1-C121S_Mutation_in_a_Preclinical_Model/22500798/1/files/39960072.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.22500807.v1', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Novel_ATP-Competitive_MEK_Inhibitor_E6201_Is_Effective_against_Vemurafenib-Resistant_Melanoma_Harboring_the_MEK1-C121S_Mutation_in_a_Preclinical_Model/22500807/1/files/39960084.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.22500801.v1', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_4_from_Novel_ATP-Competitive_MEK_Inhibitor_E6201_Is_Effective_against_Vemurafenib-Resistant_Melanoma_Harboring_the_MEK1-C121S_Mutation_in_a_Preclinical_Model/22500801/1/files/39960078.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Novel_ATP-Competitive_MEK_Inhibitor_E6201_Is_Effective_against_Vemurafenib-Resistant_Melanoma_Harboring_the_MEK1-C121S_Mutation_in_a_Preclinical_Model/22500810', 'pdf_url': 'https://figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Novel_ATP-Competitive_MEK_Inhibitor_E6201_Is_Effective_against_Vemurafenib-Resistant_Melanoma_Harboring_the_MEK1-C121S_Mutation_in_a_Preclinical_Model/22500810/1/files/39960087.pdf', 'source': {'id': 'https://openalex.org/S4306402621', 'display_name': 'INDIGO (University of Illinois at Chicago)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I39422238', 'host_organization_name': 'University of Illinois at Chicago', 'host_organization_lineage': ['https://openalex.org/I39422238'], 'host_organization_lineage_names': ['University of Illinois at Chicago'], 'type': 'repository'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/24448821', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.22500810', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Novel_ATP-Competitive_MEK_Inhibitor_E6201_Is_Effective_against_Vemurafenib-Resistant_Melanoma_Harboring_the_MEK1-C121S_Mutation_in_a_Preclinical_Model/22500810/1/files/39960087.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.8}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 37, 'referenced_works': ['https://openalex.org/W1970039331', 'https://openalex.org/W1975691556', 'https://openalex.org/W1985588649', 'https://openalex.org/W1999025555', 'https://openalex.org/W1999908952', 'https://openalex.org/W2009642188', 'https://openalex.org/W2013721954', 'https://openalex.org/W2017187984', 'https://openalex.org/W2018794234', 'https://openalex.org/W2021255160', 'https://openalex.org/W2030440427', 'https://openalex.org/W2032211985', 'https://openalex.org/W2035805526', 'https://openalex.org/W2035982599', 'https://openalex.org/W2043058822', 'https://openalex.org/W2053473615', 'https://openalex.org/W2055624262', 'https://openalex.org/W2068419651', 'https://openalex.org/W2071499259', 'https://openalex.org/W2074678272', 'https://openalex.org/W2080626878', 'https://openalex.org/W2080686146', 'https://openalex.org/W2083526450', 'https://openalex.org/W2100614336', 'https://openalex.org/W2100887597', 'https://openalex.org/W2106383417', 'https://openalex.org/W2110643890', 'https://openalex.org/W2124482167', 'https://openalex.org/W2128542677', 'https://openalex.org/W2129153475', 'https://openalex.org/W2131756681', 'https://openalex.org/W2141674733', 'https://openalex.org/W2154196978', 'https://openalex.org/W2163655212', 'https://openalex.org/W2164850852', 'https://openalex.org/W2167039800', 'https://openalex.org/W2168711434'], 'related_works': ['https://openalex.org/W4362495358', 'https://openalex.org/W4281763928', 'https://openalex.org/W4244963342', 'https://openalex.org/W2618833805', 'https://openalex.org/W2128445526', 'https://openalex.org/W2106796758', 'https://openalex.org/W2058554042', 'https://openalex.org/W2033014187', 'https://openalex.org/W2021781394', 'https://openalex.org/W1997117729'], 'abstract_inverted_index': {'Abstract': [0], 'Many': [1], 'clinical': [2, 179], 'cases': [3], 'of': [4, 17, 20, 57, 143, 152, 181], 'acquired': [5, 22, 124], 'resistance': [6, 23, 35, 132], 'to': [7, 36, 42, 133, 168], 'the': [8, 18, 25, 43, 52, 58, 75, 123, 159, 164, 170], 'BRAF': [9, 26, 64, 113], 'inhibitor': [10, 46, 61], 'vemurafenib': [11, 135], 'have': [12], 'recently': [13], 'been': [14], 'reported.': [15], 'One': [16], 'causes': [19], 'this': [21, 146], 'is': [24, 84, 104, 149, 166], 'downstream': [27], 'kinase': [28], 'point': [29, 161], 'mutation': [30, 33, 126, 162, 165], 'MEK1-C121S.': [31], 'This': [32], 'confers': [34], 'not': [37, 139], 'only': [38], 'vemurafenib,': [39], 'but': [40, 138], 'also': [41], 'allosteric': [44, 100], 'MEK': [45, 60, 87, 97, 101, 118], 'selumetinib': [47, 137], '(AZD6244).': [48], 'Here,': [49], 'we': [50], 'investigated': [51], 'pharmacologic': [53], 'activities': [54], 'and': [55, 136], 'effectiveness': [56, 142], 'novel': [59], 'E6201': [62, 83, 103, 144], 'against': [63, 107], '(v-raf': [65], 'murine': [66], 'sarcoma': [67], 'viral': [68], 'oncogene': [69], 'homolog': [70], 'B1)-V600E': [71], 'mutant': [72, 109, 129], 'melanoma': [73, 110, 115, 130], 'harboring': [74], 'MEK1-C121S': [76, 125], 'mutation.': [77], 'A': [78], 'cell-free': [79], 'assay': [80], 'confirmed': [81], 'that': [82, 122], 'an': [85], 'ATP-competitive': [86], 'inhibitor,': [88], 'meaning': [89], 'it': [90], 'has': [91], 'a': [92, 150], 'different': [93], 'binding': [94, 154], 'mode': [95], 'with': [96, 99, 112, 155], 'compared': [98, 111], 'inhibitors.': [102], 'more': [105], 'effective': [106], 'BRAF-V600E': [108, 128], 'wild-type': [114], 'based': [116], 'on': [117], 'inhibition.': [119], 'We': [120], 'found': [121], 'in': [127, 145], 'conferred': [131], 'both': [134], 'E6201.': [140, 182], 'The': [141], 'preclinical': [147], 'study': [148], 'result': [151], 'its': [153], 'MEK1': [156], 'far': [157], 'from': [158], 'C121S': [160], 'so': [163], 'unable': [167], 'influence': [169], 'MAPK': [171], 'pathway': [172], 'inhibitory': [173], 'activity.': [174], 'These': [175], 'results': [176], 'support': [177], 'further': [178], 'investigation': [180], 'Mol': [183], 'Cancer': [184], 'Ther;': [185], '13(4);': [186], '823–32.': [187], '©2014': [188], 'AACR.': [189]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2106796758', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 2}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 4}, {'year': 2017, 'cited_by_count': 3}, {'year': 2016, 'cited_by_count': 5}, {'year': 2015, 'cited_by_count': 4}, {'year': 2014, 'cited_by_count': 1}], 'updated_date': '2024-09-24T04:30:49.052598', 'created_date': '2016-06-24'}